Muscarinic acetylcholine receptors activate the acetylcholinesterase gene promoter

Journal of Physiology Paris

Volumn 92, Issue 3-4, 1998, Pages 257-264

  Nitsch, Roger M ^a   Rossner, Stefan ^b   Albrecht, Claudia ^a   Mayhaus, Manuel ^a   Enderich, Janna ^a   Schliebs, Reinhard ^b   Wegner, Michael ^a   Arendt, Thomas ^b   Von Der Kammer, H ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b Paul Flechsig Inst for Brain Res   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; IMMUNOGLOBULIN G; IMMUNOTOXIN; MUSCARINIC RECEPTOR; SAPORIN; TRANSCRIPTION FACTOR;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; BINDING SITE; BRAIN CORTEX; CHOLINERGIC NERVE; CHOLINERGIC TRANSMISSION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; FEEDBACK SYSTEM; GENE ACTIVATION; HIPPOCAMPUS; HUMAN; NONHUMAN; PROMOTER REGION; RAT;

EID: 0032105340     PISSN: 09284257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4257(98)80029-6     Document Type: Conference Paper

References (86)

1. [1] Abu-Shakra S.R., Cole A.J., Drachman D.B., Nerve stimulation and denervation induce differential patterns of immediate early gene mRNA expression in skeletal muscle, Mol. Brain Res. 18 (1993) 216-220.
2. [2] Andrä J., Lojda Z., A histochemical method for the demonstration of acetylcholinesterase activity using semipermeable membranes, Histochemistry 84 (1986) 575-579.
3. [3] Altin J.G., Kujubu D.A., Raffioni S., Eveleth D.D., Herschmann H.R., Bradshaw R.A., Differential Induction of primary-response (TIS) genes in PC12 pheochromocytoma cells and the unresponsive variant PC12nnr5, J. Biol. Chem. 266 (1991) 5401-5406.
4. [4] Bernard V., Dumartin B., Lamy E., Bloch B., Fos immunoreactivity after stimulation or inhibition of muscarinic receptors indicates anatomical specificity for cholinergic control of striatal efferent neurons and cortical neurons in the rat, Eur. J. Neurosci. 5 (1993) 1218-1225.
5. [5] Bodick N.C., Offen W.W., Levey A.I., Cutler N.R., Gauthier S.G., Satlin A., Shannon H.E., Tollefson G.D., Rasmussen K., Bymaster F.P., Hurley D.J., Potter W.Z., Paul S.M., Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease, Arch. Neurol. 54 (1997) 465-473.
6. [6] Carson KA, Geula C, Mesulam MM (1991) Electron microscopic localization of cholinesterase activity in Alzheime's brain tissue, Brain Res 540, 204-208.
7. [7] Christy B.A., Lau L.F., Nathans D., A gene activated in mouse 3T3 cells by serum growth factors encodes a protein with 'zinc finger' sequences, Proc. Natl. Acad. Sci. USA 85 (1988) 7857-7861.
8. [8] Cole A.J., Abu-Shakra A., Saffen D.W., Baraban J.M., Worley P.F., Rapid rise in transcription factor mRNAs in rat brain after electroshock-induced seizures, J. Neurochem. 55 (1990) 1920-1927.
9. [9] Cole A.J., Saffen D.W., Baraban J.M., Worley P.F., Rapid increase of an immediate early gene messenger RNA in hippocampal neurons by synaptic NMDA receptor activation, Nature 340 (1989) 474-476.
10. [10] Cole A.J., Bhat R.V., Patt C., Worley P.F., Baraban J.M., D1 dopamine receptor activation of multiple transcription factor genes in rat striatum, J. Neurochem. 58 (1992) 1420-1426.
11. [11] Coleman A.E., Geula C., Price B.H., Mesulam M.M., Differential laminar distribution of acetylcholinesterase and butyrylcholinesterase containing tangles in the cerebral cortex of Alzheimer's disease, Brain Res. 595 (1992) 340-344.
12. [12] Coso O.A., Chiariello M., Kalinec G., Kyriakis J.M., Woodgett J., Gutkind J.S., Transforming G protein-coupled receptors potently activate JNK (SAPK), J. Biol. Chem. 270 (1995) 5620-5624.
13. [13] Cummings J.L., Cyrus P.A., Bieber F., Mas J., Orazem J., Gulanski B., Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Metrifonate Study Group, Neurology 50 (1998) 1214-3221.
14. [14] Damasio A.R., Graff-Radford N.R., Eslinger P.J., Damasio H., Kassell N., Amnesia following basal forebrain lesions, Arch. Neurol. 42 (1985) 263-271.
15. [15] Davies P., Neurotransmitter-related enzymes in senile dementia of the Alzheimer type, Brain Res. 171 (1979) 319-227.
16. [16] Dragunow M., Abraham W., Hughes P., Activation of NMDA and muscarinic receptors induces nur-77 mRNA in hippocampal neurons, Mol. Brain Res. 36 (1996) 349-356.
17. [17] Ebert S.N., Wong D.L., Differential activation of the rat gene by Sp1 and Egr-1, J. Biol. Chem. 270 (1995) 17299-17305.
18. [18] Ebihara T., Saffen D., Muscarinic actylcholine receptor-mediated induction of zif268 mRNA in PC12D cells requires protein kinase C and the influx of extracellular calcium, J. Neurochem. 68 (1997) 1001-1010.
19. [19] Farber S.A., Nitsch R.M., Schulz J.G., Wurtman R.J., Regulated secretion of β-amyloid precursor protein in rat brain, J. Neurosci. 15 (1995) 7442-7451.
20. [20] Fischer W., Chen K.S., Gage F.H., Bjorklund A., Progressive decline in spatial learning and integrity of forebrain cholinergic neurons in rats during aging, Neurobiol. Aging 13 (1992) 9-23.
21. [21] Fischer W., Sirevaag A., Wiegand S.J., Lindsay R.M., Bjorklund A., Reversal of spatial memory impairments in aged rats by nerve growth factor and neurotrophins 3 and 4/5 but not by brain-derived neurotrophic factor, Proc. Natl. Acad. Sci. USA 91 (1994) 8607-8611.
22. [22] Furey M.L., Pietrini P., Haxby J.V., Alexander G.E., Lee H.C., VanMeter J., Grady C.L., Shetty U., Rapoport S.I., Schapiro M.B., Freo U., Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory, Proc. Natl. Acad. Sci. USA 94 (1997) 6512-6516.
23. [23] Gashler A., Sukhatme V.P., Early growth response protein 1 (Egr-1): Prototype of a zinc-finger family of transcription factors, Progr. Nucleic Acid. Res. 50 (1995) 191-224.
24. [24] Getman D.K., Mutero A., Inoue K., Taylor P., Transcription factor repression and activation of the human acetylcholinesterase gene, J. Biol. Chem. 270 (1995) 23511-23519.
25. [25] Geula G., Mesulam M.M., Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease, Cereb. Cortex 6 (1996) 165-177.
26. [26] Gutkind J.S., The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades, J. Biol. Chem. 27 (1998) 1839-1842.
27. [27] Hammond P., Rao R., Koenigsberger C., Brimiljoin A., Regional variation in expression of acetylcholinesterase mRNA in adult rat brain analyzed by in situ hybridization, Proc. Natl. Acad. Sci. USA 91 (1994) 10933-10937.
28. [28] Heckers S., Geula C., Mesulam M.M., Acetylcholinesterase-rich pyramidal neurons in Alzheimer's disease, Neurobiol. Aging. 13 (1992) 455-460
29. [29] Huang R.P., Fan Y., Ni Z., Mercola D., Adamson E.D., Reciprocal modulation between Sp1 and Egr-1, J. Cell. Biochem. 66 (1997) 489-499.
30. [30] Hughes P., Dragunow M., Activation of pirenzepine-sensitive muscarinic receptors induces a specific pattern of immediate-early gene expression in rat brain neurons, Mol. Brain Res. 24 (1994) 166-178.
31. [31] Hughes P., Dragunow M., Muscarinic receptor-mediated induction of Fos protein in rat brain, Neuroacid. Lett. 150 (1992) 122-126.
32. [32] Hung A.Y., Haass C., Nitsch R.M., Qiu W.Q., Citron M., Wurtman R.J., Growdon J.H., Selkoe D.J., Activation of protein kinase C inhibits cellular production of the amyloid β-protein, J. Biol. Chem. 268 (1993) 22959-22962.
33. [33] Jansen E., Ayoubi T.A., Meulemans S.M., van De Ven W.J., Regulation of human prohormone convertase 2 promoter activity by the transcription factor EGR-1, Biochemistry 328 (1997) 69-74.
34. 2-adrenergic,and bradykinin receptors, J. Neurochem. 60 (1993) 902-907.
35. [35] Kaufer D., Friedmann A., Seidman S., Soreq H., Acute stress facilities long-lasting changes in cholinergic gene expression, Nature 393 (1998) 373-377.
36. [36] Knapp M.J., Knopman D.S., Solomon P.R., Pendlebury W.W., Davis C.S., Gracon S.I., A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group, J. Am. Med. Assoc. 271 (1994) 985-991.
37. [37] Kornhauser J.M., Nelson D.E., Mayo K.E., Takahashi J.S., Regulation of jun-B messenger RNA and AP-1 activity by light and a circadian clock, Science 255 (1992) 1581-1584.
38. [38] Langer U., Albrecht C., Mayhaus M., Velden J., Wiegmann H., Klaudiny J., Müller D., von der Kammer H., Nitsch R.M., in: Younkin S.G., Tanzi R.E., Christen Y. (Eds.), Presenilins and Alzheimer's Disease, Springer Berlin, Heidelberg, New York, 1998, pp. 79-84.
39. [39] Lemaire P., Revelant O., Bravo R., Charnay P., Two mouse genes encoding potential transcription factors with indentical DNA-binding domains are activated by growth factors in cultured cells, Proc. Natl. Acad. Sci. USA 85 (1988) 4691-4695.
40. [40] Levey A.I., Muscarinic acetylcholine receptor expression in memory circuits: implications of treatment of Alzheimer's disease, Proc. Natl. Acad. Sci. USA 93 (1996) 12541-12546.
41. [41] Li Y., Camp S., Rachinsky T.L., Bongiorno C., Taylor P., Promoter elements and transcriptional control of the mouse acetycholinesterase gene, J. Biol. Chem. 268 (1993) 3563-3572.
42. [42] Lin L., Leblanc C.J., Deacon T.W., Isacon O., Chronic cognitive deficits and amyloid precursor protein elevation after selective immunotoxin lesions of the basal forebrain cholinergic system, Neuroreport 9 (1998) 547-552.
43. [43] Lin J.X., Leonnard W.J., The immediate-early gene product Egr-1 regulates the human interleukin-2 receptor beta-chain promoter through noncanonical Egr and Sp1 binding sites, Mol. Cell. Biol. 17 (1997) 3714-3722.
44. [44] Liu C., Adamson E., Mercola D., Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor beta 1, Proc. Natl. Acad. Sci. USA 93 (1996) 11831-11836.
45. [45] Massoulié J., Pezzementi L., Bon S., Krejci E., Vallette F.M., Molecular and cellular biology of the cholinesterases, Progr. Neurobiol. 41 (1993) 31-91.
46. [46] Massoulié J., Legay C., Anselmet A., Krejci E., Coussen F., Bon S., Biosynthesis and integration of acetylcholinesterase in the cholinergic synapse, Progr. Brain Res. 109 (1996) 55-65.
47. [47] Mattio T., McIlhany E., Giacobini E., Hallak M., The effects of physostigmine on acetylcholinesterase activity of CSF, plasma and brain. A comparison of intravenous and intraventricular administration in beagle dogs, Neuropharmacology 25 (1985) 1167-1177.
48. [48] Milbrand J., A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor, Science 238 (1987) 797-799.
49. [49] Morita K., Ebert S.N., Wong D.L., Role of transcription factor Egr-1 in Phorbol Ester-induced phenylethanolamine N-methyltransferase gene expression, J. Biol. Chem. 270 (1995) 11161-11167.
50. [50] Morita K., Wong D.L., Role of Egr-1 in cholinergic stimulation of phenylethanolamine N-methyltransferase promoter, J. Neurochem. 67 (1996) 1244-1351.
51. [51] Monta K., Bell R.A., Siddall B.J., Wong D.L., Neural stimulation of Egr-1 messenger RNA expression to rat adrenal gland: Possible relation to phenylethanolamine N-methyltransferase gene regulation, J. Pharmacol. Exp. Therap. 279 (1996) 379-385.
52. [52] Morris J.C., Cyrus P.A., Orazem J., Mas J., Bieber F., Ruzicka B.B., Gulanski B., Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease, Neurology 50 (1998) 1222-1230.
53. [53] Mutero A., Camp S., Taylor P., Promoter elements of the mouse acetylcholinesterase gene, J. Biol. Chem. 270 (1995) 1822-1872.
54. [54] Muthukkumar S., Han S.S., Rangnekar V.M., Bondada S., Role of Egr-1 gene expression in B-cell receptor-induced apaptosis in an immature B cell lymphoma, J. Biol. Chem. 271 (1997) 27987-27993.
55. [55] Nair P., Muthukkumar S., Sells S.F., Han S.-S., Sukhatme V.P., Rangnekar V.M., Early growth response-1-dependent apoptosis is mediated by p53, J. Biol. Chem. 272 (1997) 20131-20138.
56. [56] Nilsson O.G., Leanza G., Rosenblad C., Lappi D.A., Wiley R.G., Bjorklund A., Spatial learning impairments in rats with selective immunolesion of the forebrain cholinergic system, Neuroreport 3 (1992) 1005-1008.
57. [57] Nitsch R.M., Slack B.E., Wurtman R.J., Growdon J.H., Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors, Science 258 (1992) 304-307.
58. [58] Nitsch R.M., Farber S.A., Growdon J.H., Wurtman R.J., Release of amyloid β-protein precursor derivatives by electrical depolarization of rat hippocampal slices, Proc. Natl. Acad. Sci. USA 90 (1993) 5191-5193.
59. [59] Nitsch R.M., Growdon J.H., Role neurotransmission in the regulation of amyloid β-protein processing, Biochem. Pharmacol. 47 (1994) 1275-1284.
60. [60] Nitsch R.M., From acetylcholine to amyloid: Neurotransmitters and the pathology of Alzheimer's disease, Neurodegen. 5 (1996) 477-482.
61. [61] Nitsch R.M., Deng M., Growdon J.H., Wurtman R.J., Serotonin 5-HT2a and 5-HT2c receptors stimulate amyloid precursor protein ectodomain secretion, J. Biol. Chem. 271 (1996) 4188-4914.
62. [62] O'Donnovan K.J., Wilkens E.P., Baraban J.M., Sequential expression of Egr-1 and Egr-3 in hippocampal granule cells following electroconvulsive stimulation, J. Neurochem. 70 (1998) 1241-1248.
63. [63] Perry E.K., Johnson M., Kerwin J.M., Piggot M.A., Court J.A., Shaw P.J., Ince P.G., Brown A., Perry R.H., Convergent cholinergic activities in aging and Alzheimer's disease, Neurobiol. Aging 13 (1992) 393-400.
64. [64] Perry E.K., Perry R.H., Blessed G., Tomlinson B.E., Changes in brain cholinesterases in senile dementia of Alzheimer type, Neuropathol. Appl. Neurobiol. 4 (1978) 273-277.
65. [65] Rachinsky T.L., Camp S., Li Y., Ekström T.J., Newton M., Taylor P., Molecular cloning of mouse acetylcholinesterase: tissue distribution of alternatively spliced mRNA species, Neuron 5 (1990) 317-327.
66. [66] Rossner S., Perez-Polo J.R., Schliebs W.R., Bigl V., Differential expression of immediate early genes in distinct layers of rat cerebral cortex after selective immunolesion of the forebrain cholinergic system, J. Neurosci. Res. 38 (1994) 282-293.
67. [67] Rossner S., Schliebs W.R., Perez-Polo J.R., Bigl V., Differential changes in cholinergic markers from selected brain regions after specific immunolesion of rat cholinergic basal forebrain system, J. Neurosci. Res. 40 (1995) 31-43.
68. [68] Rossner S., Schliebs W.R., Härtig W., Bigl V., 1921gG-saporin-induced immunotoxic lesion of cholinergic basal forebrain system: neurochemical effects on cholinergic neurotransmission in rat cerebral cortex and hippocampus, Brain Res. Bull. 38 (1995) 371-381.
69. [69] Rupprecht H.D., Dann P., Sukhatme V.P., Sterzel R.B., Coleman D.L., Effect vasoactive agents on induction of Egr-1 in rat mesangial cells: correlation with mitogenicity, Am. J. Physiol. 263 (1992) F623-F636.
70. [70] Rupprecht H.D., Sukhatme V.P., Lacy J., Sterzel R.B., Coleman D.L., PDGF-induced Egr-1 expression in rat mesangial cells is mediated through upstream serum response elements, Am. J. Physiol. 265 (1993) F351-F360.
71. [71] Silverman E.S., Khachigian L.M., Lindner V., Williams A.J., Collins T., Inducible PDGF A-chain transcription in smooth muscle cells is mediated by Egr-1 displacement of Sp1 and Sp3, Am. J. Physiol. 273 (1997) H1415-H1426.
72. [72] Solomon P.R., Knapp M.J., Gracon S.I., Groccia M., Pendlebury W.W., Long-term tacrine treatment in patients with Alzheimer's disease, Lancet 348 (1996) 275-276.
73. [73] Sternfeld M., Ming G., Song H., Sela K., Timberg R., Poo M., Soreq H., Acetylcholinesterase enhances neurite growth and synapse development through alternative contributions of its hydrolytic capacity, core protein, and variable termini, J. Neurosci. 18 (1998) 1240-1249.
74. [74] Sukhatme V.P., Cao X.M., Chang L.C., Tsai-Morris C.H., Stamenkovich D., Ferreira P.C., Cohen D.R., Edwaeds S.A., Shows T.B., Curran T., Le Beau M.M., Adamson E.D., A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization, Cell 53 (1988) 37-43.
75. [75] Swirnoff A.M., Milbrandt J., DNA-binding specificity of NGFI-A and related zinc-finger transcription factors, Mol. Cell. Biol. 15 (1995) 2275-2287.
76. [76] Taylor P., Radic Z., The cholinesterases: from genes to proteins, Annu Rev. Pharmacol. Toxicol. 34 (1994) 281-320.
77. [77] Trejo J.A., Brown J.H., c-fos and c-jun are induced by muscarinic receptor activation of protein kinase c but are differentially regulated by intracellular calcium, J. Biol. Chem. 266 (1990) 7876-7882.
78. [78] von der Kammer H., Mayhaus M., Albrecht C., Enderich J., Wegner M., Nitsch R.M., Muscarinic acetylcholine receptors activate expression of the Egr gene family of transcription factors, J. Biol. Chem. 273 (1998) 14538-14544.
79. [79] Walter J., Grünberg J., Capell A., Pesold B., Schindzielorz A., Citron M., Mendla K., George-Hyslop P.S., Multhaup G., Selkoe D.J., Haass C., Proteolytic processing of the Alzheimer disease-associated presenilin-1 generates an in vivo substrate for protein kinase C, Proc. Natl. Acad. Sci. USA 94 (1997) 5349-5354.
80. [80] Wang D., Mayo M.W., Baldwin A.S. Jr., Basic fibroblast growth factor transcriptional autoregulation requires EGR-1, Oncogene 17 (1997) 2291-2299
81. [81] Wess J., Molecular basis of muscarinic acetylcholine receptor function, TIPS 14 (1993) 308-314.
82. [82] Wess J., Molecular basis of muscarinic acetlycholine receptor function, Trends Pharmacol. Sci. 14 (1993) 308-313.
83. [83] Wess J., G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition, FASEB J. 11 (1997) 346-354.
84. [84] Winkler J., Suhr S.T., Gage F.H., Thal L.J., Fisher L.J., Essential role of neocortical acetylcholine in spatial memory, Nature 375 (1995) 484-487.
85. [85] Worley P.F., Christy B.A., Nakabeppu Y., Bhat R.V., Cole A.J., Baraban J.M., Constitutive expression of zif268 in neocortex is regulated by synaptic activity, Proc. Natl. Acad. Sci. USA 88 (1991) 5106-5110.
86. [86] Arendt T., Brückner M.K., Bigt V., Marcova L., Dendritic reorganization in the basal forebrain under dgenerative conditions and its defects in Alzheimer's disease. II. Aging, Yarsakoff's disease, Parkinson's disease and Alzheimer's disease, J. Comp. Neurol. 351 (1995) 189-222.